USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Unicharm Corporation

USPTO PatentsView assignee record - 560 granted patents across 87 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).

RSS updates for this company

The verdict

According to USPTO PatentsView, Unicharm ranks #820 of 49,997 tracked US assignees by granted-patent volume, with 560 patents across 87 technology areas.

#820
of 49,997 US assignees by volume
Top 6%
by Innovation Score (56.9/100)
10.8
avg claims per patent
-67%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R820 · Foreign Corporation #820 · 560 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-WIDE · INNOV-PAR · CLAIMS-PAR · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

  • GRANTS-MID 560 grants
  • TOP-DECILE #820/49,997
  • PHOTO-FINISH Toto
  • CPC-WIDE A61F · 87 areas
  • INNOV-PAR 56.9/100
  • CLAIMS-PAR 10.8 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-DROP -67% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Toto Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Innovation-score neighbourhood around Unicharm

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Unicharm's Innovation Score is 56.9/100 (top 6% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

How Unicharm's grant cadence moved

Between 2020–2024, Unicharm Corporation received 136 grants versus 411 in 2015–2019 (-67% equal-window velocity, below median growth). Across complete PatentsView years, output peaked in 2015 at 130 grants and bottomed in 2024 at 17. Lead class A61F accounts for 65.9% of the portfolio across 87 subclasses. Volume neighbours: Electronic Arts Inc. (#816) and Zimmer, Inc. (#824).

Unicharm's three-year grant acceleration

From 2019–2021 to 2022–2024, Unicharm Corporation moved from 116 to 62 grants (0.53x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #2,609. See the growth leaderboard.

Who files at Unicharm's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Unicharm holds 560 patents at rank #820, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Unicharm

By rank, the assignees closest to #820 in granted patent volume.

Leaders in A61F (Filters Implantable Into Blood Vessels)

Other assignees with the most granted patents in Unicharm's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Unicharm, neither rank-band nor same-CPC leaders (those blocks stay above).

Unicharm's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

57 Top 6% higher than 94% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

050100150 20152016201720182019202020212022202320242025 13
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Unicharm Corporation patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 130 23.2%
2016 111 19.8%
2017 57 10.2%
2018 71 12.7%
2019 42 7.5%
2020 42 7.5%
2021 32 5.7%
2022 27 4.8%
2023 18 3.2%
2024 17 3.0%
2025partial year 13 2.3%

Which technologies does Unicharm Corporation patent most?

Top 15 of 87 technology areas

Where it ranks

Overall rank by patents

#820

of 49,997 tracked assignees

Innovation Score

56.9 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Unicharm Corporation's patent record in context - here's where to go next.

  • Unicharm Corporation's lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 65.9% of its portfolio - see every assignee active in that class. Explore A61F
  • Ranked #820 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Unicharm Corporation against Electronic Arts Inc., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 56.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.